Table 2 Baseline characteristics of patients
Variable | Statistic | informed only | informed + insert | informed + outsert | informed + insert + outsert |
|---|---|---|---|---|---|
N (%) | 47,499 (25.6) | 44,845 (24.2) | 47,602 (25.7) | 45,508 (24.5) | |
Age (years) | 66–74 (%) | 22,895 (48.4) | 21,469 (47.9) | 22,909 (48.1) | 22,096 (48.6) |
75–84 (%) | 19,603 (41.3) | 18,599 (41.5) | 19,790 (41.6) | 18,914 (41.6) | |
85+ (%) | 4911 (10.3) | 4777 (10.7) | 4903 (10.3) | 4498 (9.9) | |
Sex | Female (%) | 24,615 (51.8) | 23,364 (52.1) | 24,879 (52.3) | 23,695 (52.1) |
Years since diabetes diagnosis | Mean ± SD | 7.8 (4.1) | 7.8 (4.1) | 7.8 (4.1) | 7.8 (4.1) |
Recent diabetes diagnosis (≤2 years) | Yes (%) | 3411 (7.2) | 3126 (7.0) | 3488 (7.3) | 3178 (7.0) |
ACE inhibitor use | Yes (%) | 28,836 (60.7) | 27,114 (60.5) | 28,916 (60.8) | 27,568 (60.6) |
“Other” antihypertensive use | Yes (%) | 38,474 (81.0) | 36,224 (80.8) | 38,452 (80.8) | 36,807 (80.9) |
Cholesterol lowering agent use | Yes (%) | 30,476 (64.2) | 28,381 (63.3) | 30,213 (63.5) | 28,801 (63.3) |